Cytomegalovirus infection primary prevention

Jump to navigation Jump to search

Cytomegalovirus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cytomegalovirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cytomegalovirus infection primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cytomegalovirus infection primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cytomegalovirus infection primary prevention

CDC on Cytomegalovirus infection primary prevention

Cytomegalovirus infection primary prevention in the news

Blogs on Cytomegalovirus infection primary prevention

Directions to Hospitals Treating Cytomegalovirus infection

Risk calculators and risk factors for Cytomegalovirus infection primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

Regular hand washing is a commonly recommended step to decrease the spread of infections and healthcare providers should follow standard precautions to prevent nosocomial transmission.

Primary Prevention

  • Regular hand washing is a commonly recommended step to decrease the spread of infections, and may reduce exposures to CMV.
  • Healthcare providers should follow standard precautions to prevent nosocomial transmission.
  • HAART therapy must be initiated in patients diagnosed with HIV infection and the CD4 count must be maintained above 100cells/mm ³.
  • Vaccines against CMV are still in the research and development stage.

Prevention in patients with organ transplant

References

  1. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L; et al. (2013). "Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation". Transplantation. 96 (4): 333–60. doi:10.1097/TP.0b013e31829df29d. PMID 23896556.